Evaluating the impact of therapeutic drug monitoring strategies on clinical outcomes in paediatric inflammatory bowel disease

Documenti analoghi

• Proactive therapeutic drug monitoring and vedolizumab dose optimization in children with inflammatory bowel disease
  di: Patrick Rowland, et al.
  Pubblicazione: (2024)
• Hyperamylasaemia in paediatric inflammatory bowel disease: Aetiology, outcomes and genetic determinants
  di: Fernando Vázquez López, et al.
  Pubblicazione: (2026)
• Noninvasive monitoring with bowel ultrasound (NIMBUS) in paediatric inflammatory bowel disease: Feasibility in a single centre
  di: Zachary Green, et al.
  Pubblicazione: (2025)
• North American Society for Pediatric Gastroenterology, Hepatology, and Nutrition position paper on the therapeutic drug monitoring in pediatric inflammatory bowel disease
  di: Lina M. Felipez, et al.
  Pubblicazione: (2025)
• Chronic nonbacterial osteomyelitis associated with pediatric inflammatory bowel disease: A multicenter retrospective study from the Paediatric inflammatory bowel disease Porto Group of ESPGHAN
  di: Manar Matar, et al.
  Pubblicazione: (2025)